Although revenues still show signs of COVID-19 impact, robotic procedures and implant pull-through accelerate, and companies continue roll out new spine enabling technology and strategize how to maximize the remainder of 2022.
The Q122 WW CAS Spine Market was up year-over-year according to SmartTRAK Financial Dashboard. Medtronic* (MDT) remained the market leader with 59.5% share, followed by Globus* (GMED) and other enabling tech competitors, including Stryker* (SYK) and Brainlab*.
Among the many topics covered in detail in our comprehensive Q122 CAS Spine Market Recap* are:
- Complete Q122 CAS Spine Market Overview and Highlights
- SmartTRAK's Expert Analysis and Insights
- News, Revenues, Data, Charts and Shares
- New and Existing Platforms Driving Q122 Performance
- What’s on the Horizon for the Rest of 2022?
- Q122 Robotics, Strategic Alliance and Regulatory Highlights
For Q4FY22, Medtronic reported its Neurosurgery business grew in the low-single digits with mid-20’s growth in robotics and high-single digit growth in navigation, driven by capital equipment demand. The Company also noted record numbers for the Spine business, largely driven by ...
*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
SmartTRAK is a comprehensive, easy-to-use, business intelligence solution for the Life Sciences Industry that provides breaking updates on pertinent company news, potential treatments and guidance, international survey results, statistical analysis by country, studies, trial results, financial impact and more. All subscribers receive a Daily Updates email containing the latest need-to-know news curated by our expert analysts. It's the perfect way to start your day! If you would like to learn more about SmartTRAK, just click here.
